IL17A and rheumatoid arthritis: Regarding the effect of anti-inflammatory drugs on IL-37 level, IL-37 expression together with TNF-α, IL-6, and IL-17A during the use of disease-modifying anti-rheumatic drugs (DMARDs), especially drug responders, in RA, was significantly decreased rather than before the initiation of DMARDs [11].